IP Library Granted Patent US 8,192,761
Granted Patent B2
US 8,192,761 · App. 11/912,463 · Granted Jun 5, 2012

Granular preparation containing biguanide compound

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,192,761
App. No.
11/912,463
Granted
Jun 5, 2012
Kind
B2
Abstract

A granular preparation containing a biguanide compound and a solidification-preventive agent does not solidify during storage and can avoid the difficulty in dosing.

Claims (26)

1. A granular preparation comprising (a) metformin or a pharmaceutically acceptable salt thereof, (b) an organic acid in an amount effective to increase palatability, said acid being selected from the group consisting of citric acid and malic acid, and (c) a solidification-preventive agent selected from the group consisting of pullulan, dextrin, calcium chloride, light anhydrous silicic acid, and mixtures thereof,

wherein

the metformin or pharmaceutically acceptable salt thereof is present in an amount of 10-90 wt % of the total,

and the solidification-preventive agent is present in an amount of 0.5-10 wt % of the total.

2. The granular preparation according to claim 1 , wherein (a) is metformin hydrochloride.

3. The granular preparation according to claim 1 , wherein the solidification-preventive agent is dextrin.

4. The granular preparation according to claim 1 , wherein the solidification-preventive agent is pullulan.

5. The granular preparation according to claim 1 , having a particle size of not more than 1700 μm.

6. The granular preparation according to claim 1 , which is in a dosage fonn of an orally disintegrating form.

7. The granular preparation according to claim 1 , further comprising a water-soluble sugar alcohol.

8. The granular preparation according to claim 7 , wherein the water-soluble sugar alcohol is erythritol.

9. The granular preparation according to claim 8 , wherein erythritol is contained in 10-90 wt % of the total.

10. The granular preparation according to claim 1 , further comprising a high-intensity sweetener.

11. The granular preparation according to claim 7 , further comprising a high-intensity sweetener.

12. The granular preparation according to claim 7 , wherein the solidification-preventive agent is dextrin.

13. The granular preparation according to claim 2 , wherein the solidification-preventive agent is dextrin.

14. The granular preparation according to claim 7 , wherein the solidification-preventive agent is pullulan.

15. The granular preparation according to claim 2 , wherein the solidification-preventive agent is pullulan.

16. The granular preparation according to claim 1 , wherein the organic acid is citric acid.

17. The granular preparation according to claim 1 , wherein the solidification-preventive agent is present in an amount of 1-10 wt % of the total.

18. The granular preparation according to claim 1 , wherein the solidification-preventive agent is present in an amount of 2-10 wt % of the total.

19. The granular preparation according to claim 4 , wherein the organic acid is citric acid.

20. The granular preparation according to claim 4 , wherein the solidification-preventive agent is present in an amount of 1-10 wt % of the total.

21. The granular preparation according to claim 4 , wherein the solidification-preventive agent is present in an amount of 2-10 wt % of the total.

22. The granular preparation according to claim 1 , wherein citric acid is present in an amount of 0.9 wt % of the total.

23. The granular preparation according to claim 1 , wherein malic acid is present in an amount of 1.3 wt % of the total.

Assignments (2)
CHANGE OF NAME Recorded Aug 25, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 033606/0307 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2007
From: OCHIAI, YASUSHI; MATSUI, YASUHIRO
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 020008/0796 →